Skip to main content

Table 3 Patient characteristics for the bladder cancer patients included in the discovery and hematuria urine series

From: BladMetrix: a novel urine DNA methylation test with high accuracy for detection of bladder cancer in hematuria patients

  BlCa cases, discovery series (n = 26) BlCa cases, hematuria series (n = 93)
Gender
Male 65% (17/26) 78% (73/93)
Female 35% (9/26) 22% (20/93)
Median age, yr (range) 75 (49–93) 69 (48–91)
Stage (n)
Ta 11 43
Ta + CIS 1
T1 22
T1 + CIS 9
T2 3 8
T2 + CIS 1 1
T3 2 1
T3 + CIS 2
T4 1 2
CIS 5 7
Grade
Low-grade 31% (8/26) 31% (29/93)*
High-grade 69% (18/26) 66% (61/93)*
  1. BlCa Bladder cancer; yr Year
  2. *Grade is missing for three of the patients